- Record: found
- Abstract: not found
- Article: not found
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
György Németh ,
István Laszlovszky ,
Pál Czobor ,
Erzsébet Szalai ,
Balázs Szatmári ,
Judit Harsányi ,
Ágota Barabássy ,
Marc Debelle ,
Suresh Durgam ,
István Bitter ,
Stephen Marder ,
W Wolfgang Fleischhacker
March 2017
March 2017
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Although predominant negative symptoms of schizophrenia can be severe enough to cause
persistent impairment, effective treatment options are lacking. We aimed to assess
the new generation antipsychotic cariprazine in adult patients with predominant negative
symptoms.